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Objective Among individuals at high risk for diabetes 
identified through a population survey, we performed an 
intervention study with basic lifestyle advice aiming to 
prevent diabetes.
Research design and methods Among 50 806 
participants in the HUNT3 Survey (2006–2008), 5297 
individuals with Finnish Diabetes Risc Score (FINDRISC 
≥15 were invited to an oral glucose tolerance test (OGTT) 
and an education session with lifestyle advice, and 2634 
(49.7%) attended. Among them, 2380 people without 
diabetes were included in the prevention study with 
repeated examinations and education sessions after 6, 
12, and 24 months. We examined participation, diabetes 
incidence, glycemia, and adiposity during follow-up.
Results Of 2380 participants, 1212 (50.9%) participated 
in ≥3 of the four examinations. Diabetes was detected 
in 3.5%, 3.1%, and 4.0% of individuals at the 6-month, 
12-month, and 24-month examinations, respectively, 
indicating a 10.3% 2-year diabetes incidence. Mean 
(95% CI) increases from baseline to 2-year follow-up 
were 0.30 (0.29 to 0.32) percentage points (3.3 (3.2 
to 3.5) mmol/mol) for Hemoglobin A1c, 0.13 (0.10 to 
0.16) mmol/L for fasting serum-glucose, 0.46 (0.36 to 
0.56) mmol/L for 2-hour OGTT s-glucose, 0.30 (0.19 to 
0.40) kg/m2 forbody mass index (BMI) (all p<0.001) and 
−0.5 (-0.9 to −0.2) cm for waist circumference (p=0.004), 
with broadly similar estimates by baseline age, sex, 
education, depressive symptoms, BMI, physical activity, 
and family history of diabetes. Only 206 (8.7%) participants 
had evidence of >5% weight loss during follow-up; their 
fasting and 2-hour s-glucose did not increase, and HbA1c 
increased less than in other participants.
Conclusion Basic lifestyle advice given to high-risk 
individuals during three group sessions with 6-month 
intervals was not effective in reducing 2-year diabetes risk.
InTROduCTIOn
The worldwide prevalence of type 2 diabetes 
is increasing and prevention of the disease is 
an important public health priority.1 Inten-
sive lifestyle intervention has proved effec-
tive in preventing type 2 diabetes among 
high-risk individuals in clinical trials, with 
short-term (~3 years) relative risk reduc-
tions of 50–60% and 30–40% long-term rela-
tive risk reductions (7–20 years),2–6 but may 
be difficult to implement on a population 
level. In primary healthcare settings, more 
feasible, but still quite intensive lifestyle 
intervention with almost monthly follow-up 
sessions has also been effective in reducing 
weight,7 8 particularly in people following 
official lifestyle recommendations on weight 
management; diet with less saturated fat, 
sugar and highly refined carbohydrates; and 
more physical activity.7 9 This weight reduc-
tion would presumably lead to lower risk of 
diabetes,7 9 although the effect of these less 
extensive interventions on glycemia and 
diabetes incidence is sparsely studied.8 
significance of this study
What is already known about this subject?
 ► Intensive lifestyle intervention is effective 
in preventing type 2 diabetes. Also, lifestyle 
intervention with almost monthly follow-up 
sessions in primary healthcare settings may reduce 
weight and prevent diabetes.
What are the new findings?
 ► Basic lifestyle advice given to individuals at high 
risk of type 2 diabetes during three group sessions 
with 6-month intervals was not effective in 
reducing 2-year diabetes risk.
How might these results change the focus of 
research or clinical practice?
 ► As our low-grade intervention with basic lifestyle 
advice was ineffective in preventing diabetes, 
improved population strategies or more intensive 
individual-level intervention seems necessary to 
prevent type 2 diabetes.
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Based on this evidence, diabetes prevention guide-
lines recommend that high-risk individuals are offered 
low-threshold, multifactorial and intensive interventions 
in local communities.10 11 However, these interventions 
are resource demanding, and the number of eligible 
users is high. For example, in Norway, approximately 
10% of the adult population is estimated to be at high 
risk of diabetes, indicated by FINDRISC ≥15.12 Only 60% 
of the municipalities in Norway offer the recommended 
low-threshold multifactorial intervention (‘Healthy Life 
Centers’)13 and <10% of the high-risk population partic-
ipate,12 13 and the situation is likely comparable in other 
countries.14 15
Low-grade, basic lifestyle advice could be a feasible 
alternative that would reach out to a higher propor-
tion of the high-risk individuals, but the effects of 
low-grade lifestyle advice on glycemia and adiposity are 
insufficiently studied. The control groups in the type 
2 diabetes prevention trials often lost 0.1–0.8 kg body 
weight following basic lifestyle advice,5 16 suggesting 
that even low-grade lifestyle intervention could reduce 
adiposity and hyperglycemia. However, people volun-
teering to intensive lifestyle trials may be particularly 
motivated for lifestyle change, making their results less 
relevant for the general population. Further, it is unclear 
whether subgroups of the population may respond 
differently to lifestyle advice. Preventive strategies against 
type 2 diabetes should benefit all, including higher risk 
groups such as people with low socioeconomic status and 
depression. Some studies, though not all,17 18 suggest that 
lifestyle intervention against type 2 diabetes or cardiovas-
cular diseases may be less effective among people with 
depression19 20 or low socioeconomic status.21
We performed a 2-year intervention study with basic 
lifestyle advice aiming to prevent diabetes among individ-
uals at high risk of type 2 diabetes identified through a 
population survey. We examined diabetes incidence and 
measures of glycemia and adiposity during follow-up, and 
examined how participation and changes in glycemia 
and adiposity differed by baseline characteristics.
ReseaRCH desIgn and meTHOds
study population
In 2006–2008, all inhabitants aged ≥20 years in Nord-Trøn-
delag County, Norway, were invited to the HUNT3 
Survey (2006–2008), and 50 806 (54.1%) participated.22 
The HUNT3 Study population was one of 25 European 
cohorts included in the Diabetes in Europe —Prevention 
using Lifestyle, physical Activity and Nutritional interven-
tion (DE-PLAN) Study, whose main goal was to improve 
the capability to prevent type 2 diabetes in Europe.23 All 
HUNT3 participants had their diabetes risk predicted 
using the FINDRISC questionnaire.12 A FINDRISC score 
of ≥15 out of 26 was considered as high risk for type 2 
diabetes.24 25 All 5297 participants with FINDRISC ≥15 and 
no previously known diabetes were informed about 
their elevated diabetes risk on site and were invited to 
a follow-up examination including questionnaires and 
clinical and laboratory measurements, including an oral 
glucose tolerance test (OGTT). They received written 
information by surface mail on how to prepare for the 
OGTT and made an appointment for the examination 
by phone. Among the 5297 invited HUNT participants, 
2634 (49.7%) attended the examination. Among these, 
laboratory measurements were lacking from one person, 
and the OGTT revealed that 253 persons had previously 
unknown diabetes (fasting serum glucose ≥7.0 mmol/L 
or 2-hour serum glucose ≥11.1 mmol⁄L). The latter 
group was referred to their general practitioner (GP) 
for routine diabetes care, leaving 2380 participants for 
the 2-year intervention study. Both the HUNT3 Survey 
and the DE-PLAN intervention were approved by the 
Regional Committee for Medical and Health Research 
Ethics of Central Norway and the participants signed 
a written consent. The participants were invited to all 
OGTTs by phone. They were invited to the educational 
sessions by surface mail, and no reminders were given. 
The intervention study was not registered in a Clinical 
Trials Register, as this was not required for such commu-
nity-based uncontrolled interventions beginning enrol-
ment before 1 July 2008, according to the International 
Committee of Medical Journal Editors.
The de-PLan intervention in HunT3
The intervention consisted of clinical examinations 
and subsequent group educational sessions at four time 
points: within 2 months after the HUNT3 Survey and 
approximately after additional 6, 12, and 24 months. 
(The educational session at 24 months took place at 
the end of follow-up and thus did not influence the 
outcomes in this study.) The educational sessions were 
held in each of the 23 municipalities, and on average ~30 
invitees participated at each session. Each group session 
lasted 2.5 hours and had four main themes. First, infor-
mation on diabetes, diabetes risk, and the importance of 
prevention. Second, nutrition and dietary recommenda-
tions, including advice on having 3–4 main meals and 
1–2 healthy snack meals per day, increasing the intake 
of fiber and polyunsaturated fat, eating five portions of 
fruit, berries and vegetables every day, plentiful intake 
of legume and wholegrain products, and the use of light 
dairy products. In addition, they were shown visually 
how much sugar, calories, fat, and types of fat there are 
in different sweets and fast food and shown healthy full 
meal and snack alternatives. Third, physical activity advice 
based on recommendations from the Norwegian Directo-
rate of Health and in line with European recommenda-
tions,26 including advice to perform moderate physical 
activity such as rapid walking or biking at least 30 min/
day. Fourth, information on ongoing local low-threshold 
opportunities for physical activity. A physician (KM) held 
the first educational session. A nurse with a clinical post-
graduate education in Diabetic Nursing (1-year full-time 
study) held the educational sessions during follow-up. 
Themes 2 and 3 were elaborated, with a course in Nordic 
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walking and a particular focus on diet in session 2, and on 
coping in session 3.
In a few municipalities, sessions 2 and 3 were merged 
into one session, because session 2 was not completed 
until the time approached for session 3. Brochures from 
the Norwegian Directorate of Health about nutrition and 
physical activity were handed out for free, and a healthy 
evening meal was provided to the participants, the focus 
being on easily prepared, healthy, and inexpensive food.
Questionnaires
The participants completed self-administered question-
naires at the HUNT3 Survey and at each DE-PLAN exam-
ination. The FINDRISC items12 were included in the 
main HUNT3 questionnaire that was sent by surface mail 
together with the invitation to participate in HUNT3 and 
returned at the HUNT3 examination.22 A second ques-
tionnaire, handed out at the HUNT3 examination and 
returned by mail in a prepaid envelope, included, among 
other items, the Hospital Anxiety and Depression Scale 
(HADS).27 HADS consists of 14 questions, seven of them 
related to depression (Hospital Anxiety and Depression 
Scale-Depression (HADS-D); each question scored from 
zero to three, given a maximum score of 21 for HADS-D. 
We classified a score ≥8 on the seven HADS-D questions 
as an indication of depression.28 Of the 2380 participants 
in the DE-PLAN intervention, 2114 (85.7%) answered 
all seven questions in HADS-D and 74 (3.1%) answered 
five or six items. For them, we weighted the non-missing 
answers by multiplying them by 7/5 or 7/6, respectively. 
At the DE-PLAN examinations, all participants also 
reported their number of completed years of education.
Clinical measurements
At all four DE-PLAN examinations, HbA1c and fasting 
and 2-hour OGTT capillary and serum glucose concen-
trations were measured after overnight fasting. Partici-
pants with fasting capillary glucose >8.5 mmol/L were 
not offered an OGTT, but had a fasting blood sample 
drawn for HbA1c and serum glucose measurement. 
OGTT was performed by giving fasting participants 75 g 
of glucose dissolved in 300 mL of water, to be consumed 
within 5 min. If plasma-referenced capillary blood 
glucose was ≥7.0 mmol/L fasting or ≥8.9 mmol/L 2 hours 
after the glucose load, the participant was given a referral 
to her/his GP and was recommended follow-up. If the 
venous samples, which were analyzed the following day, 
indicated diabetes or impaired glucose tolerance (IGT), 
the participant’s GP also received information by surface 
mail. According to the 1999 WHO criteria,29 diabetes 
was defined as fasting serum glucose ≥7.0 mmol/L or 
2-hour serum glucose ≥11.1 mmol⁄L; IGT as fasting serum 
glucose <7.0 mmol/L and a 2-hour serum glucose of 
7.8–11.0 mmol/L. If fasting or 2-hour serum-glucose indi-
cated diabetes, the participant was not invited to further 
examinations; the further clinical follow-up of diabetes 
was entrusted to the participants’ GP. One of the study 
nurses participated at almost all the OGTTs, to ensure 
equal procedures according to the written study protocol 
throughout the study.
Laboratory measurements
Venous samples for serum analyses were centrifuged after 
a minimum of 25, but preferably no longer than 30 min 
after blood sampling. Fasting and 2-hour serum samples 
for glucose determination and fasting EDTA blood 
samples for HbA1c were analyzed at the Department of 
Clinical Chemistry at Levanger Hospital (Nord-Trøndelag 
Hospital Trust). Serum glucose was analyzed by hexoki-
nase/Glucose-6-phosphate dehydrogenase methodology 
(Abbott, Clinical Chemistry, Illinois, USA). HbA1c was 
measured immunoturbidimetrically by using a micropar-
ticle agglutination inhibition method (Multigent, Abbott 
Laboratories, Illinois, USA). To enable necessary imme-
diate GP referral, plasma-referenced capillary glucose 
was also measured at the clinical examination site imme-
diately after sampling by glucose dehydrogenase meth-
odology using HemoCue photometer (HemoCue AB, 
Ängelholm, Sweden).
statistical analysis
We estimated age-adjusted and sex-adjusted changes 
(with 95% CI) in HbA1c, fasting and 2- hour OGTT 
serum glucose, BMI, and waist circumference, from base-
line to the 6-month, 12-month, and 24-month follow-up 
examinations. The associations were analyzed using 
linear mixed models with random slopes. This approach 
uses all available information and is less susceptible 
to bias under the assumption of missing at random.30 
From the regression model, we predicted mean values 
(with 95% CI) of the glycemia and adiposity measures, 
fixing age and sex at their mean values. The results are 
reported overall and by baseline age (<50, 50–69, or ≥70 
years), sex, education level (≤10, 11–13, or ≥14 years), 
and HADS depression score (<8 or ≥8). In additional 
analyses, we similarly estimated changes in glycemia and 
adiposity by baseline BMI, physical activity, and family 
history of diabetes. Further, we estimated changes in 
glycemia during follow-up according to weight reduc-
tion (>5% weight reduction from baseline to at least one 
of the follow-up examinations) and leisure time physical 
activity (≥3-hour weekly activity in at least one of the 
follow-up examinations) during follow-up. These char-
acteristics have earlier been associated with successful 
diabetes prevention in a randomized trial of intensive 
lifestyle intervention.5
We used logistic regression analysis to examine how 
participation differed by baseline age, sex, education, 
and depressive symptoms and estimated the age-adjusted 
and sex-adjusted predicted probability of participation 
in each subgroup. We estimated both the probability of 
attending the baseline DE-PLAN examination among all 
5297 invitees and the probability of continued participa-
tion (defined as participating in at least three out of four 
DE-PLAN examinations) among the 2380 participants of 
the intervention study. Data were analyzed using Stata 
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Figure 1 Flow chart of the HUNT3 Survey and the Diabetes in Europe —Prevention using Lifestyle, physical Activity and 
Nutritional intervention (DE-PLAN) intervention study.
Clinical Care/Education/Nutrition
version 13.1 for Windows (StataCorp, College Station, 
Texas, USA).
ResuLTs
Figure 1 shows a flow chart of the study population. 
Table 1 shows baseline characteristics of all 5297 HUNT3 
participants invited to the baseline OGTT and of the 2380 
participants of the DE-PLAN intervention. Among the 
2380 participants, 1217 (51.1%) participated at 6-month 
follow-up, and 1165 (48.9%) participated at each of the 
examinations at 12 and 24 months. Mean (SD) interval 
from the HUNT3 Survey to the baseline DE-PLAN exam-
ination was 1.5 (1.6) months. Mean (SD) intervals from 
the baseline DE-PLAN examination to the follow-up 
examinations were 7.0 (1.7), 13.9 (2.3), and 23.5 (1.9) 
months for the 6-month, 12-month, and 24-month exam-
inations, respectively.
Overall, 2634 (49.7%) of invitees took part in the base-
line examination, with similar attendance for women 
and men, but moderately higher partaking among 
those <50 years (58.5%) compared with 50–69 (52.1%) 
or ≥70 years of age (43.1%) (online supplementary 
table 1). Attendance was slightly lower among those 
with depressive symptoms (47.4% vs 52.3%). Among the 
2380 DE-PLAN participants, 50.9% participated in at 
least three out of the four DE-PLAN examinations. Such 
continued participation did not markedly differ between 
the groups, but was highest in the age group 50–69 
years (54.1%), slightly higher among men than women 
(54.3% vs 48.8%), highest among those having 11–13 
years of education (58.4%), and slightly lower among 
participants with depressive symptoms (46.6% vs 53.5%) 
(online supplementary table 2).
New diabetes was identified in 43 (3.5%), 36 (3.1%), 
and 47 (4.0%) individuals at the 6-month, 12-month, 
and 24-month examinations. Under the assumption that 
diabetes incidence was similar in participants and non-par-
ticipants during follow-up, these 126 observed incident 
cases of diabetes correspond to a 2-year diabetes inci-
dence of 10.3% (245 cases) among the 2380 participants. 
The diagnosis was based on a single diagnostic test, but 
58 (46.0%) of the 126 observed incident cases of diabetes 
had at least two test values suggestive of diabetes at the 
time of diagnosis (fasting serum glucose ≥7.0 mmol/L, 
2-hour serum glucose ≥11.1 mmol⁄L, or HbA1c ≥6.5% (48 
mmol/mol)).
Overall, mean HbA1c increased by 0.30 (95% CI 0.29 
to 0.32) percentage points (pp) (3.3 (3.2 to 3.5) mmol/
mol), from 5.67% (38 mmol/mol) to 5.98% (42 mmol/
mol), during the 2-year follow-up (p<0.001). The only 
sign of a favorable course was a very modest (0.06 pp) and 
temporary decline in HbA1c from 6-month to 12-month 
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Table 1 Baseline characteristics of the 5297 HUNT3 participants invited to the Diabetes in Europe —Prevention using 
Lifestyle, physical Activity and Nutritional intervention (DE-PLAN) baseline examination and of the 2380 participants of the DE-




2380 participants of the 
intervention study
Age (years) 64.5 (11.9) 62.7 (11.6)
Women (%) 60.6 60.8
BMI (kg/m2) 31.0 (4.2) 31.3 (4.1)
Waist circumference (cm)
  Women 101.5 (11.1) 102.0 (11.1)
  Men 107.5 (8.6) 108.2 (8.3)
Physical activity ≥30 min/day (%)† 55.0 56.8
Daily intake of fruit, berries, or vegetables (%) 59.2 59.6
Ever treated for hypertension (%) 60.9 61.2
Ever measured high blood glucose (%) 23.6 25.5
First-degree relative with diabetes (%)‡ 71.4 69.8
Second-degree relative with diabetes (%)§ 55.5 62.1
Education level (years) (%)
  ≤10 NA 54.4
  11–13 NA 24.8
  ≥14 NA 20.8
HADS-D score ≥8 (%) 13.9 12.5§
HbA1c (%) NA 5.7 (0.5)
  (mmol/mol) NA 39 (6)
Fasting s-glucose (mmol/L) NA 5.5 (0.5)
2-hour oral glucose tolerance test s-glucose 
(mmol/L)
NA 6.1 (1.8)
*Calculated among participants with valid information. Information was available in ≥97% of participants, except that education level was 
missing in 7% of the 2380 participants, and HADS-D was missing in 14% of the 5297 invitees and 11% of the 2380 participants. HbA1c, 
fasting and 2-hour oral  glucose tolerance test s-glucose, and education level were measured/queried only in the 2380 participants.
†Physical activity at least 30 min daily at work or during leisure time.
‡Parent, sibling, or offspring with diabetes.
§Grandparent, uncle, aunt, or first cousin with diabetes.
Clinical Care/Education/Nutrition
follow-up. The 2-year increase in HbA1c was ~0.3 pp in all 
subgroups by sex, age, education level, or HADS-D score 
at baseline (figure 2).
Fasting serum glucose was stable from baseline to 
6-month follow-up, but subsequently increased and was 
0.13 mmol/L (95% CI 0.10 to 0.16) higher at 2-year 
follow-up than at baseline (p<0.001). The 2-year increase 
in fasting serum glucose was slightly stronger among men 
than women (0.17 (95% CI 0.12 to 0.21) mmol/L vs 0.11 
(95% CI 0.07 to 0.14) mmol/L), but did not substantially 
differ by age, education level, or HADS-D (figure 3).
Two-hour OGTT serum glucose was also stable from base-
line to 6-month follow-up, but increased thereafter and 
was 0.46 mmol/L (95% CI 0.36 to 0.56) higher at 2 years 
than at baseline (p<0.001). There was a 0.3–0.6 mmol/L 
2-year increase in 2-hour OGTT serum glucose across 
all subgroups, except for a less convincing 0.21 (95% CI 
−0.03 to 0.44) mmol/L increase among people with ≥14 
years of education (online supplementary figure 1).
BMI increased by 0.30 kg/m2 (95% CI 0.19 to 0.40) 
during the 2-year follow-up (p<0.001). The 2-year BMI 
increase was stronger at age <50 years (0.79 kg/m2, 
95% CI 0.51 to 1.08) and absent at age ≥70 years (0.05 kg/
m2, 95% CI −0.14 to 0.25), but was otherwise 0.2–0.5 kg/
m2 in all subgroups (figure 4).
Waist circumference was 2.4 cm lower at 6-month 
follow-up compared with baseline, but subsequently 
increased and was 0.5 cm (95% CI 0.2 to 0.9) lower at 
2-year follow-up than at baseline (p=0.004). Changes 
in waist circumference were similar across subgroups 
(online supplementary figure 2).
Mean changes (with 95% CI) in measures of glycemia 
and adiposity from baseline to each of the follow-up 
examinations, overall and by subgroups of age, sex, 
education level, or HADS-D at baseline, are provided in 
online supplementary table 3. We additionally examined 
changes in measures of glycemia and adiposity by base-
line levels of BMI, physical activity, and family history of 
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Figure 2 Mean (95% CI) HbA1c at baseline and 6-month, 12-month, and 24-month follow-up, overall and by sex (A), and by 
baseline age (B), education (C), and Hospital Anxiety and Depression Score-Depression (D).
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diabetes and observed that glycemia and BMI increased 
from baseline to 2-year follow-up in all subgroups 
(online supplementary table 4).
Among the 2380 participants, 1194 (50.2%) reported to 
have ≥3-hour weekly leisure time physical activity at at least 
one follow-up examination, 206 (8.7%) had >5% weight 
reduction from baseline to at least one of the follow-up 
examinations, and 145 (6.1%) fulfilled both these 
criteria. Participants with >5% weight reduction did not 
increase their fasting and 2-hour OGTT serum glucose 
values from baseline to 2-year follow-up, and participants 
with both >5% weight reduction and ≥3-hour weekly 
physical activity had lower 2-year increase in HbA1c (0.20 
pp, 95% CI 0.13 to 0.26), compared with participants who 
fulfilled neither criteria (0.32 pp, 95% CI 0.29 to 0.36) 
(online supplementary table 5).
The 2380 participants provided a total of 5927 exam-
inations, of which 643 (10.8%) were performed >3 
months earlier or later than the planned time points 
(which was within 2 months after the HUNT3 Survey and 
approximately after additional 6, 12, and 24 months). In 
a sensitivity analysis, we re-examined the 2-year changes 
in glycemia and adiposity after exclusion of these 643 
measurements, but the results remained similar to those 
observed in the main analysis (data not shown).
COnCLusIOns
In this 2-year population-based uncontrolled intervention 
study, high-risk individuals were informed about their 
elevated risk of type 2 diabetes and received basic lifestyle 
advice aimed at preventing diabetes at baseline and after 
6 and 12 months. Glycemia and BMI increased during 
the 2-year follow-up, and the estimated 2-year diabetes 
incidence was 10.3%. Glycemia and BMI increased in 
all subgroups by baseline age, sex, education, depres-
sive symptoms, BMI, physical activity, or family history of 
diabetes.
The strengths of the study include the large sample 
size, which allowed precise estimates of change both 
overall and in subgroups. Our participants were selected 
using a widely recommended type 2 diabetes prediction 
tool (FINDRISC), which makes the study relevant for a 
primary care type 2 diabetes prevention setting.11 31 32 
The population-based design is a particular asset; this 
design means that the results are likely more represen-
tative for a general population of individuals at high risk 
for type 2 diabetes, compared with evidence from trials 
more likely to enrol people who are highly motivated for 
lifestyle change.33 Even the control groups in these trials 
may have had favorable lifestyle changes and weight loss 
beyond what we may expect in the general population. 
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Figure 3 Mean (95% CI) fasting s-glucose at baseline and 6-month, 12-month, and 24-month follow-up, overall and by sex 
(A), and by baseline age (B), education (C), and Hospital Anixety and Depression Score-Depression (D).
Clinical Care/Education/Nutrition
The discrepancy between gradual increases in glycemia 
and BMI in our population-based sample, and the favor-
able weight changes observed after basic lifestyle advice 
in the control groups of intensive lifestyle trials,5 34 may 
be explained by a stronger motivation for lifestyle change 
among people enrolled in these trials. We believe that 
the present study informs more realistically on what can, 
or cannot, be achieved by providing basic lifestyle advice 
to prevent diabetes in the general population.
A limitation of our study is the lack of a control group, 
which means that we do not know whether the observed 
changes during follow-up were different from what we 
would have observed if no lifestyle advice had been given. 
Nonetheless, the estimated 10.3% 2-year diabetes inci-
dence is not lower than what we would expect without 
any intervention based on previous studies of FINDRISC 
and risk of OGTT-defined diabetes.5 35 36 Further, our 
observed weight increase contrasts with the substantial 
weight loss observed in Randomized controlled trials 
(RCTs) of intensive lifestyle intervention5 16 and with the 
moderate weight loss observed after less intensive inter-
vention in primary healthcare settings.7 8 Additionally, 
only 8.7% of our participants had evidence of >5% weight 
loss during the intervention, compared with ~40% in the 
intervention groups and 13% in the usual care groups 
in RCTs.5 16 Thus, our results seem to imply that our 
low-grade intervention was not sufficient to achieve a 
clinically relevant beneficial effect on diabetes preven-
tion. Nonetheless, we cannot exclude that other forms 
of providing basic lifestyle advice could have been more 
effective, for example, with more frequent intervention 
or individual rather than group-level education sessions.
The participation rates in the HUNT3 Survey and the 
DE-PLAN intervention were ~50%, broadly in line with 
most recent national and international population-based 
studies.37 Participation in the HUNT3 Survey was lower 
in people with lower socioeconomic status and psychi-
atric disorders; individuals who might have a particularly 
high risk of diabetes and obesity.38 39 Thus, the diabetes 
incidence and increases in glycemia and obesity during 
follow-up might have been even larger if these high-
risk groups had participated to a higher extent. Most 
participants did not attend all examinations, and a few 
participants were excluded during follow-up due to the 
development of diabetes. To reduce the impact that 
these missing observations may have had on the esti-
mated changes in glycemia and adiposity, we analyzed 
the data using mixed models, as recommended for this 
purpose.30 For waist circumference, we observed an 
unforeseen pattern with an abrupt decline from baseline 
to 6-month follow-up, followed by a steady increase. We 
cannot exclude that subtle differences in measurement 
technique between the HUNT3 and the DE-PLAN study 
nurses may have contributed to the initial drop in waist 
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Figure 4 Mean (95% CI) BMI at baseline and 6-month, 12-month, and 24-month follow-up, overall and by sex (A), and by 
baseline age (B), education (C), and Hospital Anxiety and Depression Score-Depression (D).
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circumference. As we did not observe a corresponding 
reduction in BMI, we are reluctant to interpret the decline 
in waist circumference as a true decline in adiposity, and 
in any circumstance, the decline appeared short-lasting, 
as the mean value at 2-year follow-up approached the 
value at baseline.
We observed no evidence of improvement in glycemia 
in any subgroup, and the differences in changes in 
glycemia and adiposity between subgroups were minor. 
One might expect that people with higher education 
and no depressive symptoms would have been more 
compliant to lifestyle advice, but we saw no evidence of 
a more beneficial course in these individuals, except that 
the 2-hour OGTT serum glucose increased less among 
those having a high education level. BMI increased more 
strongly at younger age; this could indicate that younger 
people are more likely to follow physical activity advice 
and gain more muscle mass, which would contribute 
to higher BMI. Alternatively, the stronger BMI increase 
in the younger participants could indicate a steeper 
obesogenic trajectory in younger individuals, but if so, we 
would have expected to see a similarly stronger increase 
in waist circumference at younger age.40 Analogously, a 
stronger increase in BMI in younger versus older individ-
uals has also been shown in a study of long-term weight 
change in the entire HUNT Study population from 
1984–1986 to 2006–2008.40
High participation is one prerequisite for a successful 
diabetes prevention program at the population level. 
We estimate that the 2634 attendants at the baseline 
DE-PLAN examination constitute about one-third of the 
total number of eligible people with elevated FINDRISC 
in the underlying population, that is, the adult popu-
lation of Nord-Trøndelag county.12 Only half of these 
participants participated in at least three of the examina-
tions. Thus, the majority of eligible high-risk participants 
chose not to participate and complete our intervention, 
even though relatively little effort was required from each 
participant. Although participation did not markedly 
differ between subgroups, participation was lower at old 
age and among people with depressive symptoms. The 
lower participation among people with depressive symp-
toms is in line with other studies.41
In summary, the substantial 2-year diabetes incidence, 
the consistent increases in glycemia and BMI, the rela-
tively low participation, and the low proportion achieving 
substantial weight reduction indicate that our low-grade 
intervention with basic lifestyle advice did not have clini-
cally meaningful effect on diabetes prevention overall or 
in subgroups by age, sex, education level, depressive symp-
toms, BMI, physical activity, or family history of diabetes. 
Our prevention strategy of informing high-risk individ-
uals about their elevated diabetes risk and providing 
them with basic lifestyle advice is likely of similar intensity 
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as the preventive measures often offered to high-risk indi-
viduals in a primary care setting. However, our strategy 
appeared ineffective and improved population strategies 
or more intensive individual-level intervention seems 
necessary to prevent type 2 diabetes.
author affiliations
1HUNT Research Centre, Department of Public Health and Nursing, NTNU, 
Norwegian University of Science and Technology, Levanger, Norway
2Department of Endocrinology, St Olavs Hospital, Trondheim University Hospital, 
Trondheim, Norway
3Department of Clinical and Molecular Medicine, NTNU, Norwegian University of 
Science and Technology, Trondheim, Norway
4Department for Clinical Neurosciences and Preventive Medicine, Danube 
University Krems, Krems an der Donau, Austria
5Department of Public Health, University of Helsinki, Helsinki, Finland
6Department of Public Health and Nursing, NTNU, Norwegian University of Science 
and Technology, Trondheim, Norway
acknowledgements The authors thank the participants who made this study 
possible. The authors also thank the diabetic nurse Siv Helene Nordholm, nurse 
Turid Austheim and the other nurses involved in this study for their excellent work. 
The Nord-Trøndelag Health Study (The HUNT Study) is a collaboration between the 
HUNT Research Centre (Faculty of Medicine and Health Sciences, NTNU, Norwegian 
University of Science and Technology), the Nord-Trøndelag County Council, the 
Central Norway Regional Health Authority and the Norwegian Institute of Public 
Health.
Contributors KM designed and organized the study, and JT led the overall 
Diabetesin Europe—Prevention using Lifestyle, physical Activity and Nutritional 
intervention project. AJ, BOÅ and JHB analyzed the data, and all authors interpreted 
the results. AJ and BOÅ wrote the manuscript. JH, KM, JT, JHB and SMC critically 
reviewed the manuscript. AJ is the guarantor of this work and, as such, had full 
access to all the data in the study and takes responsibility for the integrity of the 
data and the accuracy of the data analysis. 
Funding  The HUNT Diabetes in Europe—Prevention using Lifestyle, physical 
Activity and Nutritional intervention Study received financial support from 
the Norwegian Directorate of Health and the Commission of the European 
Communities, Directorate C—Public Health, Grant Agreement No 2004310. 
Competing interests None declared.
Patient consent Not required.
ethics approval Regional ethical committee—Central Norway. 
Provenance and peer review Not commissioned; externally peer reviewed.
Open access This is an Open Access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited and the use is non-commercial. See: http:// creativecommons. org/ 
licenses/ by- nc/ 4. 0/
© Article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2018. All rights reserved. No commercial use is permitted unless otherwise 
expressly granted.
RefeRences
 1. World Health Organization. Global report on diabetes Geneva. 2016 
http:// apps. who. int/ iris/ bitstream/ 10665/ 204871/ 1/ 9789241565257_ 
eng. pdf? ua=1
 2. Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle 
interventions to prevent diabetes in the China Da Qing 
Diabetes Prevention Study: a 20-year follow-up study. Lancet 
2008;371:1783–9.
 3. Knowler WC, Fowler SE, Hamman RF, et al. 10-year follow-up of 
diabetes incidence and weight loss in the diabetes prevention 
program outcomes study. Lancet 2009;374:1677–86.
 4. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in 
preventing NIDDM in people with impaired glucose tolerance. The 
Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537–44.
 5. Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 
2 diabetes mellitus by changes in lifestyle among subjects with 
impaired glucose tolerance. N Engl J Med 2001;344:1343–50.
 6. Haw JS, Galaviz KI, Straus AN, et al. Long-term sustainability 
of diabetes prevention approaches: a systematic review and 
meta-analysis of randomized clinical trials. JAMA Intern Med 
2017;177:1808-1817.
 7. Dunkley AJ, Bodicoat DH, Greaves CJ, et al. Diabetes prevention in 
the real world: effectiveness of pragmatic lifestyle interventions for 
the prevention of type 2 diabetes and of the impact of adherence to 
guideline recommendations: a systematic review and meta-analysis. 
Diabetes Care 2014;37:922–33.
 8. Johnson M, Jones R, Freeman C, et al. Can diabetes prevention 
programmes be translated effectively into real-world settings and 
still deliver improved outcomes? A synthesis of evidence. Diabet 
Med 2013;30:3–15.
 9. Hamman RF, Wing RR, Edelstein SL, et al. Effect of weight loss 
with lifestyle intervention on risk of diabetes. Diabetes Care 
2006;29:2102–7.
 10. National Institute for Health and Care Excellence. Type 2 diabetes 
prevention: population and community-level interventions London: 
National Institute for Health and Care Excellence (NICE) 2017. 2016 
https://www. nice. org. uk/ guidance/ ph35
 11. The Norwegian Directorate of Health. Nasjonale faglige retningslinjer 
for diabetes (National professional guidelines for diabetes) 
Oslo: The Norwegian Directorate of Health 2017. 2017 https:// 
helsedirektoratet. no/ retningslinjer/ diabetes
 12. Jølle A, Midthjell K, Holmen J, et al. Impact of sex and age on the 
performance of FINDRISC: the HUNT Study in Norway. BMJ Open 
Diabetes Res Care 2016;4:e000217.
 13. Thonstad TEoM. Frisklivssentralar i kommunane Kartlegging og 
analyse av førebyggande og helsefremjande arbeid og tilbod Oslo: 
Statistics Norway, 2016.
 14. Dietz WH, Baur LA, Hall K, et al. Management of obesity: 
improvement of health-care training and systems for prevention and 
care. Lancet 2015;385:2521–33.
 15. Downer SCA, White KL, Shaw S, et al. PATHS providin access 
to healthy solutions beating type 2 diabetes: recommendations 
for federal policy reform: The Center for Health Law and Policy 
Innovation of Harvard Law School, 2015.
 16. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the 
incidence of type 2 diabetes with lifestyle intervention or metformin. 
N Engl J Med 2002;346:393–403.
 17. Rautio N, Jokelainen J, Oksa H, et al. Do depressive symptoms have 
an impact on the effectiveness of lifestyle counseling in prevention 
of type 2 diabetes? One-year follow-up of FIN-D2D. Prim Care 
Diabetes 2014;8:43–7.
 18. Linde JA, Simon GE, Ludman EJ, et al. A randomized controlled trial 
of behavioral weight loss treatment versus combined weight loss/
depression treatment among women with comorbid obesity and 
depression. Ann Behav Med 2011;41:119–30.
 19. Cezaretto A, Pakseresht M, Sharma S, et al. Influence of depression 
on cardiometabolic responses to a lifestyle intervention in at-risk 
individuals. J Affect Disord 2015;174:516–21.
 20. Huffman JC, Celano CM, Beach SR, et al. Depression and cardiac 
disease: epidemiology, mechanisms, and diagnosis. Cardiovasc 
Psychiatry Neurol 2013;2013:1–14.
 21. Beauchamp A, Backholer K, Magliano D, et al. The effect of obesity 
prevention interventions according to socioeconomic position: a 
systematic review. Obes Rev 2014;15:541–54.
 22. Krokstad S, Langhammer A, Hveem K, et al. Cohort Profile: the 
HUNT Study, Norway. Int J Epidemiol 2013;42:968–77.
 23. Schwarz PE, Lindström J, Kissimova-Scarbeck K, et al. The 
European perspective of type 2 diabetes prevention: diabetes in 
Europe--prevention using lifestyle, physical activity and nutritional 
intervention (DE-PLAN) project. Exp Clin Endocrinol Diabetes 
2008;116:167–72.
 24. Lindström J, Tuomilehto J. The diabetes risk score: a practical tool 
to predict type 2 diabetes risk. Diabetes Care 2003;26:725–31.
 25. Saaristo T, Peltonen M, Lindström J, et al. Cross-sectional evaluation 
of the Finnish Diabetes Risk Score: a tool to identify undetected type 
2 diabetes, abnormal glucose tolerance and metabolic syndrome. 
Diab Vasc Dis Res 2005;2:67–72.
 26. Paulweber B, Valensi P, Lindström J, et al. A European evidence-
based guideline for the prevention of type 2 diabetes. Horm Metab 
Res 2010;42(Suppl 1):S3–36.
 27. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. 
Acta Psychiatr Scand 1983;67:361–70.
 28. Bjelland I, Dahl AA, Haug TT, et al. The validity of the Hospital 
Anxiety and Depression Scale. An updated literature review. J 
Psychosom Res 2002;52:69–77.
 on 25 F











are: first published as 10.1136/bm





10 BMJ Open Diab Res Care 2018;6:e000509. doi:10.1136/bmjdrc-2018-000509
Clinical Care/Education/Nutrition
 29. Alberti KG, Zimmet PZ. Definition, diagnosis and classification 
of diabetes mellitus and its complications. Part 1: diagnosis and 
classification of diabetes mellitus provisional report of a WHO 
consultation. Diabet Med 1998;15:539–53.
 30. Rabe-Hesketh S, Skrondal A. Multilevel and longitudinal modeling 
using Stata. 2nd ed. College Station, Tex: Stata Press, 2008.
 31. National Institute for Health and Care Excellence. Type 2 diabetes in 
adults: management London: National Institute for Health and Care 
Excellence (NICE). 2017 https://www. nice. org. uk/ guidance/ ng28/ 
chapter/ 1- Recommendations
 32. Center for Disease Control and Prevention. National diabetes 
prevention program Atlanta, GA US Department of Health & Human 
Services. 2016 https://www. cdc. gov/ diabetes/ prevention/ index. html
 33. Toerien M, Brookes ST, Metcalfe C, et al. A review of reporting of 
participant recruitment and retention in RCTs in six major journals. 
Trials 2009;10:52.
 34. Vermunt PW, Milder IE, Wielaard F, et al. A lifestyle intervention to 
reduce Type 2 diabetes risk in Dutch primary care: 2.5-year results of 
a randomized controlled trial. Diabet Med 2012;29:e223–31.
 35. Gerstein HC, Santaguida P, Raina P, et al. Annual incidence 
and relative risk of diabetes in people with various categories 
of dysglycemia: a systematic overview and meta-analysis of 
prospective studies. Diabetes Res Clin Pract 2007;78:305–12.
 36. de Vegt F, Dekker JM, Jager A, et al. Relation of impaired fasting 
and postload glucose with incident type 2 diabetes in a Dutch 
population: The Hoorn Study. JAMA 2001;285:2109–13.
 37. Galea S, Tracy M. Participation rates in epidemiologic studies. Ann 
Epidemiol 2007;17:643–53.
 38. Renn BN, Feliciano L, Segal DL. The bidirectional relationship of 
depression and diabetes: a systematic review. Clin Psychol Rev 
2011;31:1239–46.
 39. Langhammer A, Krokstad S, Romundstad P, et al. The HUNT 
study: participation is associated with survival and depends on 
socioeconomic status, diseases and symptoms. BMC Med Res 
Methodol 2012;12:143.
 40. Midthjell K, Lee CM, Langhammer A, et al. Trends in overweight and 
obesity over 22 years in a large adult population: the HUNT Study, 
Norway. Clin Obes 2013;3:12–20.
 41. Laatikainen T, Dunbar JA, Chapman A, et al. Prevention of type 2 
diabetes by lifestyle intervention in an Australian primary health care 
setting: Greater Green Triangle (GGT) Diabetes Prevention Project. 
BMC Public Health 2007;7:249.
 on 25 F











are: first published as 10.1136/bm
jdrc-2018-000509 on 9 M
ay 2018. D
ow
nloaded from
 
